drugset / Trial / NCT02141425
A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP015K in Healthy Subjects
Phase 1
Completed
16 enrolled
Astellas Pharma Global Development, Inc.
Janssen Biotech, Inc. · collab
RandomizedParallel-groupDouble-blindBasic science
Summary
The purpose of this study is to assess the safety, tolerability and pharmacokinetics of single ascending doses of ASP015K.
Timeline
- Start
- 2014-03
- Primary completion
- 2014-04
- Completion
- 2014-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | peficitinib | Small molecule | — | Oral |
Indications
No indication recorded.